all report title image
  • Published In : Feb 2024
  • Code : CMI6663
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global elbow replacement market was valued at US$ 144.2 Mn in 2023 and is expected to reach US$ 200.4 Mn by 2031 growing at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Elbow replacement surgery, also known as elbow arthroplasty, provides orthopedic treatment for patients suffering from arthritis or damage to the elbow joint. There are two primary types of elbow replacement prostheses available.

The first is a total elbow replacement, which involves resurfacing both the inner and outer sides of the elbow joint. A total elbow prosthesis replaces both the humeroulnar and ulnohumeral joints of the elbow with artificial components made of metals, plastics, or ceramic materials. This offers the most complete replacement of the joint, but requires more bone to be removed during surgery. The second option is a radial head replacement, which involves only replacing the rounded head of the radius bone on the outer side of the elbow. This preserves more native bone but provides arthroplasty for less of the joint.

Both types aim to reduce pain and restore the function of the elbow. Their advantages include improved range of motion and ability to participate in everyday activities. However, total elbow replacements carry risks of loosening, infection, nerve, or blood vessel damage from the more invasive surgery. Radial head replacements have less risk of complications but may not provide complete pain relief or mobility compared to a total replacement. Overall, elbow arthroplasty can greatly improve quality of life for patients with significant elbow arthritis

Global Elbow Replacement Market Regional Insights:

  • North America has established itself as the dominant region in the global elbow replacement market. The partial elbow replacement sub-segment accounts for the largest share within the elbow replacement in type segment in North America. Partial elbow replacement procedures are generally preferred by both surgeons and patients in the region as they allow the preservation of the patient's natural elbow joint. In April 2020, according to a study by the American Academy of Orthopaedic Surgeons, over the past 5 years there has been a 15% increase in the number of partial elbow replacement procedures performed in the U.S. as compared to total elbow replacement. This trend can be attributed to advancements in surgical techniques and implant design that have made partial elbow replacement a viable option even for patients with complex fractures and arthritis damage localized to one portion of the elbow. For example, companies, such as Zimmer Biomet, have developed innovative modular partial elbow systems that offer surgeons greater flexibility in reconstructing the elbow joint.
  • Asia Pacific has emerged as the fastest-growing regional market for elbow replacement. The partial elbow replacement sub segment has emerged as the leading segment for the elbow replacement market in the Asia Pacific region. According to data released by national joint registries of countries in the countries  such as Australia and New Zealand, the rate of partial elbow replacements has steadily increased over the past 5 years. Partial elbow replacements are gaining prominence as they allow surgeons to replace only the affected or damaged parts of the elbow joint. This preservation of native bone and tissues enables faster recovery and return to daily activities. Younger and more active patients in Southeast Asian countries especially prefer partial replacements to maintain maximum elbow motion.

Analyst View: The elbow replacement market is poised to show strong growth in the coming years. Driven by an aging population prone to elbow injuries and osteoarthritis, the number of elbow replacement procedures is expected to rise significantly. Additionally, improved prosthetic designs and surgical techniques have made elbow replacements a more viable option for younger patients with joint damage from high-impact sports or accidents. However, the market still faces some restraints. The recovery time for elbow replacements is typically longer than for hip or knee replacements, which could cause some patients to delay surgery. Additionally, the elbow is a complex joint, making the surgeries more technically challenging for orthopedic surgeons. This skill barrier could limit the number of surgeons comfortable performing the procedure. Opportunities exist to expand the market into younger patient demographics. As active lifestyles and extreme sports gain popularity, so too will joint injuries in younger populations. Improved prosthetics with greater range of motion could encourage more early intervention in these groups. Geographically, North America currently dominates the market but Asia Pacific is growing rapidly as medical tourism increases and a vast aging population drives the demand. The increasing medical capabilities and economic strength in countries like China and India will drive Asia Pacific to become the fastest growing regional market.

Figure 1. Global Elbow Replacement Market Share (%), by Region, 2024


To learn more about this report, request a free sample copy

Global Elbow Replacement Market Drivers:

The rising geriatric population:  The rising geriatric population is a significant factor expected to drive the elbow replacement market. This demographic trend has implications for the healthcare industry and specifically impacts markets related to joint health and mobility such as those for elbow replacement procedures and devices. As people age, they are more susceptible to a range of degenerative joint diseases, including osteoarthritis and rheumatoid arthritis, which often lead to chronic pain and impaired mobility. The elbow joint, being crucial for arm movement, can significantly impact quality of life when affected by such conditions. Elderly individuals, therefore, represent a growing patient population for elbow replacement surgeries. These procedures can offer pain relief and restore function, allowing older adults to maintain independence and an active lifestyle. Furthermore, advancements in medical technology mean that elbow replacement prosthetics have become more sophisticated and could provide better outcomes and longer implant lifespan, making the procedure more appealing to both patients and orthopedic surgeons .In terms of market dynamics, the aging global population could lead to an increase in the volume of elbow replacement surgeries performed, thus driving demand for the necessary implants and instruments. This could encourage manufacturers to focus on developing and marketing joint prostheses that cater specifically to the needs of the elderly demographic. For instance, in 2020, according to data provided by the World Health Organization (WHO), the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The share of the population aged 60 years and over will increase from 1 million in 2020 to 1.4 million. By 2050, the world’s populations of people aged 60 years and older will double (2.1 million). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

Technological advancements in elbow implants: Technological advancements in elbow implants are indeed expected to be a key driver in the growth of the elbow replacement market. As these innovations improve, they bring several benefits that can increase the demand for elbow replacement procedures New materials and engineering designs can lead to implants that last longer and are more durable, reducing the need for revision surgeries and increasing their appeal among younger patients. Technological improvements can result in elbow implants that provide a greater range of motion and more closely mimic the natural movement of the elbow joint, improving patient quality of life. Advances in imaging and manufacturing, including the use of 3D printing, allow for the creation of customized implants that fit the specific anatomical requirements of individual patients, leading to better outcomes. The development of advanced surface coatings that reduce wear and the risk of infection can lead to fewer complications post-surgery. With the advent of minimally invasive surgical techniques, recovery times can be shortened, and post-operative pain can be minimized, bolstering the market as more patients become willing to undergo elbow replacement. Implants equipped with sensors that provide real-time data on function and stress loads can help healthcare professionals monitor recovery and ongoing joint health. Advances in material science contribute to the development of more biocompatible implants that reduce the risk of rejection and other adverse immune responses. In summary, these advancements are expected to lead to an increase in the number of elbow replacement surgeries by offering improved patient outcomes, addressing the needs of a more extensive range of patients, and ultimately expanding the market

The growing prevalence of osteoarthritis: The growing prevalence of osteoarthritis is a significant factor that can drive the elbow replacement market forward. Osteoarthritis is a common form of arthritis that causes the cartilage, which cushions the joints, to break down. This degeneration leads to pain, stiffness, and impaired movement at the joint, which, when occurring at the elbow, can severely limit a person's functional ability and quality of life. Since osteoarthritis is associated with aging and wear-and-tear of the joint, an increase in the number of individuals with osteoarthritis can be attributed to the expanding elderly population globally, as well as lifestyle factors that contribute to joint deterioration. As more people are diagnosed with osteoarthritis of the elbow, the demand for surgical interventions, including total elbow replacement, may rise. Elbow replacement surgery replaces the damaged parts of the elbow joint with artificial components to restore joint function and relieve pain. This can be particularly beneficial for those who have not experienced sufficient relief through medication or other conservative treatments. The following points outline how the rising rates of osteoarthritis are expected to impact the elbow replacement market higher number of osteoarthritis cases will likely translate to a greater number of elbow replacement surgeries being performed. As surgeries increase, so will the demand for the implants and devices used in these procedures. With more procedures occurring, healthcare spending on elbow replacement surgeries, including pre-operative and post-operative care, is expected to grow. The need for effective treatment options for osteoarthritis sufferers provides opportunities for companies in the market to develop and provide innovative elbow implant solutions. The increased prevalence of the condition may encourage more research into improved surgical techniques and prosthetic designs. The impact may vary globally due to differences in the prevalence of osteoarthritis, healthcare infrastructure, and access to orthopedic care. For companies involved in the elbow replacement market, understanding the epidemiology of osteoarthritis, patient demographics, and emerging trends in joint replacement will be key to addressing market needs.

The increasing demand for minimally invasive surgeries (MIS): The increasing demand for minimally invasive surgeries is indeed poised to be a significant driver for the elbow replacement market. Minimally invasive surgery (MIS) techniques offer numerous advantages over traditional open surgery such as smaller incisions, reduced blood loss, less postoperative pain, shorter hospital stay, and quicker recovery times. These benefits are becoming more recognized by both healthcare professionals and patients, leading to a rising preference for MIS. The advancements in surgical instruments, imaging technologies, and robotic-assisted systems are facilitating the adoption of minimally invasive approaches in various orthopedic surgeries, including elbow replacements. As these technologies continue to improve, they allow surgeons to perform complex procedures with higher precision and control, contributing to better patient outcomes. In the context of the elbow replacement market, the growing demand for MIS translates to an increased need for specialized implants and tools designed for these techniques. This demand encourages innovation among medical device manufacturers and can lead to the development of new products tailored for minimally invasive elbow replacement procedures. Additionally, as MIS becomes more common, there is the potential for an expansion of the patient base for elbow replacement. Patients who may have previously been averse to the idea of undergoing open surgery due to concerns about recovery time and potential complications might reconsider in light of the advantages offered by MIS.

Global Elbow Replacement Market Opportunities:

  • The development of bio-absorbable implants: The development of bio-absorbable implants is indeed a promising opportunity within the elbow replacement market. Bio-absorbable, or biodegradable, implants are designed to be absorbed by the body over time, eliminating the need for a second surgery to remove the hardware once healing has occurred. This innovative approach can revolutionize how elbow injuries and conditions are treated. As these implants degrade naturally, patients would not usually require additional surgery for implant removal, which can reduce the long-term impact on the patient's health and overall healthcare costs. Traditional metal implants can sometimes lead to complications such as infection, allergic reactions, or stress shielding. Bio-absorbable materials may mitigate these risks by eventually leaving no foreign material in the body. These implants can be engineered to encourage natural bone growth and healing, potentially improving outcomes for patients. Advancements in fabrication techniques, such as 3D printing, can allow bio-absorbable implants to be tailored to individual patient anatomy and needs. Bio-absorbable implants are particularly advantageous in pediatric orthopedics, as they reduce the risk of affecting bone growth and do not require removal surgeries, which can be significant considerations in a growing child. The push to develop bio-absorbable implants can drive technological innovation in the market, creating new growth segments and expanding the potential user base for these products. Opportunities for collaboration between device manufacturers, research institutions, and medical practitioners to develop and test new bio-absorbable materials can lead to advancements in the field. As the medical industry continues to recognize the potential benefits of these devices, the demand for bio-absorbable implants could increase, providing a significant opportunity for growth in the elbow replacement market. Companies that invest in R&D for bio-absorbable technology could tap into new customer segments and establish a competitive advantage.
  • Emerging markets in developing countries: Emerging markets in developing countries offer significant opportunities for the elbow replacement market. These regions represent a substantial and relatively untapped patient base due to their large populations and increasing incidence of conditions that require elbow replacement, such as arthritis and trauma injuries. Here's a brief analysis of how these markets can be leveraged. Developing countries often feature growing middle-class populations with increasing disposable incomes and rising healthcare expenditures. As these trends continue, more individuals in these regions can afford and access advanced healthcare treatments, including joint replacements. Governments and private sectors in emerging markets are increasingly investing in healthcare infrastructure. The expansion of hospitals and clinics, coupled with improvements in medical facilities, aids in providing the necessary setting for complex surgeries like elbow replacements. Awareness about health issues and available treatments is also on the rise in these regions, leading to greater demand for medical interventions that improve quality of life such as elbow replacement surgeries. Some developing countries are becoming hubs for medical tourism, drawing patients from all over the world due to the lower costs of medical procedures without compromising on quality. This can include orthopedic surgeries like elbow replacements.

Global Elbow Replacement Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2023: US$ 144.2 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2024 to 2031 CAGR: 4.2% 2031 Value Projection: US$ 200.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East:  GCC Countries, Israel, and Rest of Middle East
  • Africa:  South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Partial Elbow Replacement and Total Elbow Replacement
  • By Material: Metal, Ceramic, Polyethylene, and Others
  • By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others
Companies covered:

Wright Medical Group N.V., Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Service, Inc., Corin Group, Stryker, Smith+Nephew, DJO, LLC, Arthrex, Inc., Limacorporate S.p.A., Acumed LLC, CONMED Corporation, implantcast GmbH, BioMedtrix, LLC, Meril Life Sciences Pvt. Ltd., and RCH ORTHOPAEDICS

Growth Drivers:
  • The rising geriatric population
  • Technological advancements in elbow implants
  • The growing prevalence of osteoarthritis
  • The increasing demand for minimally invasive surgeries (MIS)
Restraints & Challenges:
  • The lack of skilled professionals
  • The alternative treatments options

 Global Elbow Replacement Market Trends:

  • Increasing adoption of customized and patient-specific implants: the increasing adoption of customized and patient-specific implants is indeed a key market trend within the elbow replacement sector. The trend toward personalization in medical treatments reflects the broader movement in healthcare towards more tailored solutions that meet individual patient needs. Here are some insights into why customized and patient-specific implants are gaining traction and their impact on the market. Custom-designed implants can conform more precisely to a patient's unique anatomy, potentially leading to improved outcomes and greater joint function. They are also thought to reduce the risk of implant-related complications, such as improper fit or alignment, which can lead to additional revision surgeries. Advancements in 3D imaging and printing technologies have made it easier and more cost-efficient to produce bespoke implants. Software algorithms can now accurately predict the optimal implant shape and size based on medical imaging, which helps in designing patient-specific implants. Offering customized implants allows manufacturers to differentiate their products within a crowded market. This trend increases the added value to both surgeons and patients, contributing to brand loyalty and market share growth. As patients become more informed and involved in their treatment plans, many prefer options that are specifically tailored for them, increasing demand for customized solution. Positive patient outcomes and experiences can further drive the adoption of these implants through word-of-mouth and patient testimonials. Surgeons are increasingly recognizing the benefits of utilizing customized implants in complex cases where standard implants may not provide optimal results. Training programs for surgeons on the use and benefits of patient-specific implants can further increase their adoption. Custom implants may face unique regulatory challenges due to their non-standard nature. However, regulatory bodies are adapting, and clear guidelines are being established, facilitating market entry for these product. Establishing favorable reimbursement scenarios for customized implants is crucial, as this can be a major factor in adoption rates
  • The rise in the number of ambulatory surgery centers (ASCs): The rise in the number of ambulatory surgery centers (ASCs) is indeed a key market trend in the elbow replacement market. Ambulatory surgery centers, also known as outpatient or same-day surgery centers, offer a convenient and cost-effective alternative to hospital-based surgeries, without the need for an overnight stay. This trend is driven by several factors that align well with the changing preferences and needs of both patients and healthcare providers. ASCs typically have lower overhead costs compared to hospitals, which can result in savings for patients and insurers. This is particularly relevant for elective procedures like elbow replacements, which are becoming more common. ASCs offer patients the convenience of undergoing surgery and returning home on the same day, which can lead to higher patient satisfaction and a better overall experience. Improvements in minimally invasive surgical techniques and pain management have made it possible to perform more complex procedures, such as elbow replacements, on an outpatient basis. The risk of postoperative infection can be lower in ASCs compared to hospitals, as the patient turnover is higher, and the exposure to hospital-acquired infections is reduced. Insurance companies are increasingly providing coverage for procedures performed in ASCs due to the cost benefits and high-quality outcomes, which encourages their adoption. The aging population and rising prevalence of conditions like arthritis are leading to an increase in the number of elbow replacement surgeries, thus facilitating the growth of ASCs. For stakeholders in the elbow replacement market, the growth of ASCs presents an opportunity to address a more cost-conscious healthcare environment while maintaining high standards of care. The trend towards surgeries being performed in ASCs may also encourage manufacturers to develop and market elbow replacement products specifically designed for an outpatient setting.

Global Elbow Replacement Market Restraints:

  • The lack of skilled professionals: The lack of skilled professionals is indeed a challenge that can hamper the growth of the elbow replacement market. Elbow replacement is a complex orthopedic procedure, and successful outcomes heavily depend on the surgeon's expertise. Elbow replacements require precise surgical technique and an in-depth understanding of the elbow's anatomy. A shortfall in experienced orthopedic surgeons can lead to suboptimal patient outcomes and potentially increase complication rates. The amount of time and resources required to train a surgeon to proficiency in elbow replacements is significant. A lack of training opportunities can impede the growth of the professional workforce capable of performing these procedures. As new technologies and surgical techniques develop, there is a need for ongoing education for existing professionals. The inability to keep up with such advancements can limit the adoption of innovative elbow replacement solutions. In some regions, particularly rural or under-resourced areas, there may be a significant lack of access to skilled orthopedic professionals. This can create disparities in the availability of elbow replacement surgeries. The inability to meet the demand for elbow replacements due to a lack of skilled surgeons can constrain market expansion, despite the existence of a large patient pool requiring the procedure. A shortage of skilled professionals can lead to longer waiting times for surgeries and increased healthcare costs, as specialists may command higher fees, making the procedure less accessible to patients. To address these challenges, strategies such as enhancing orthopedic training programs, offering fellowships in joint replacement surgery, encouraging continuous professional development, and utilizing technology such as surgical simulators or remote learning tools, can be employed. Additionally, the use of telemedicine and remote consultations could help mitigate geographic limitations in access to skilled professionals.
  • Alternative treatments options: Alternative treatments options can impact the elbow replacement market. Many patients with elbow discomfort may respond well to conservative treatments such as physical therapy, corticosteroid injections, and pain management medications without needing replacement surgery. Advancements in regenerative medicine, such as platelet-rich plasma (PRP) injections and stem cell therapies, offer potential disease-modifying effects that may reduce the need for surgical intervention. Patients may prefer non-surgical options due to the lower risk profile, the absence of lengthy recovery times, and the avoidance of potential complications associated with surgery. Non-surgical treatments can be more cost-effective than elbow replacement surgery, particularly for patients with limited insurance coverage or those from lower-income backgrounds. The development of improved orthopedic devices, such as custom braces and supports, might provide sufficient symptom relief and functional improvement to postpone or negate the need for a surgical solution. There is a growing emphasis on holistic and lifestyle-based approaches to healthcare that prioritize natural and less invasive interventions over surgical procedures. Clinical guidelines may evolve in response to research findings, potentially recommending alternative treatments as first-line management for certain elbow conditions. While these alternative treatments pose challenges to the elbow replacement market, they also prompt important strategic considerations for market players. Companies can diversify their product offerings to include medical devices and treatments that support these alternative therapies.

Recent Developments:

New product Launches & Approvals:

  • In August 2022, OSSIO, Inc., an orthopedic fixation technology company, announced the U.S. launch and the first commercial use of OSSIOfiber Suture Anchors, for use in foot/ankle, shoulder, knee, hand/wrist, and elbow surgeries

Acquisition, Collaborations, and Partnerships:

  • On January 31, 2024, the American Academy of Orthopaedic Surgeons (AAOS), the largest medical association of musculoskeletal specialists, expanded its partnership with PatientIQ, a healthcare technology company, to offer Shoulder & Elbow Registry (SER) participants a turnkey solution for data submission. The integration of PatientIQ's cloud-based platform offers a seamless experience that simplifies the ability to automate the collection and normalization of outcomes data.
  • In July 2022, Acumed LLC, a medical device company, announced the acquisition of ExsoMed Corporation, a provider of innovative solutions for hand surgery that enhanced Acumed LLC’s comprehensive portfolio of upper extremity solutions for simple to complex injuries.
  • In June 2022, CONMED Corporation, a medical device company, announced the acquisition of In2Bones Global Inc., a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, and elbow) and lower (foot and ankle) extremities

Figure 2. Global Elbow Replacement Market Share (%), by Type, 2024


To learn more about this report, request a free sample copy

Top Companies in the Global Elbow Replacement Market:

  • Wright Medical Group N.V.
  • Integra LifeSciences Corporation
  • Zimmer Biomet
  • Johnson & Johnson Service, Inc.
  • Corin Group
  • Stryker
  • Smith+Nephew
  • DJO, LLC
  • Arthrex, Inc.
  • Limacorporate S.p.A.
  • Acumed LLC
  • CONMED Corporation
  • implantcast GmbH
  • BioMedtrix, LLC
  • Meril Life Sciences Pvt. Ltd.

Definition: Elbow replacement is a branch of nanotechnology that involves the design, creation, and use of nanoscale structures and devices through the manipulation and self-assembly of nucleic acids, primarily DNA. This discipline leverages the unique molecular recognition properties of DNA and other nucleic acids to construct complex, three-dimensional structures at the nanometer scale.

Few Other Promising Reports in the Medical Device Industry

Drug Discovery Outsourcing Market

T-cell Lymphoma Market

Clinical Trial Management System Market

Stem Cells Market

Frequently Asked Questions

The lack of skilled professionals and the alternative treatments options are some factor can hamper the growth of the market.

The rising geriatric population, technological advancements in elbow implants, the growing prevalence of osteoarthritis, and the increasing demand for minimally invasive surgeries (MIS) are some factors driving the market growth over the forecast period.

The partial elbow replacement segment accounted for the largest share of the global elbow replacement market.

Wright Medical Group N.V., Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Service, Inc., Corin Group, Stryker, Smith+Nephew, DJO, LLC, Arthrex, Inc., Limacorporate S.p.A., Acumed LLC, CONMED Corporation, implantcast GmbH, BioMedtrix, LLC, Meril Life Sciences Pvt. Ltd., and RCH ORTHOPAEDICS are the major players operating in the market.

North America is expected to account for the largest share of the global elbow replacement market.

The global elbow replacement market is expected to grow at a CAGR of 4.2% from 2024 to 2031.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Reliability and Reputation


Reliability and Reputation


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo